Contact
Please use this form to send email to PR contact of this press release:
Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock
TO:
Please use this form to send email to PR contact of this press release:
Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock
TO: